Skip to main content
. 2020 Jun 2;15(1):492–500. doi: 10.1515/med-2020-0047

Figure 4.

Figure 4

Downregulation of miR-491-5p enhanced hVSMC viability and migration and reduced the apoptosis. The hVSMCs were pretreated with inhibitor control or miR-491-5p inhibitor for 48 h. (a) The effect of miR-491-5p inhibitor on hVSMC viability was monitored by the MTT assay. (b) The effect of miR-491-5p inhibitor on hVSMC migration was determined by the transwell assay. (c and d) Apoptosis of hVSMCs was evaluated by the flow cytometric analysis. Data are shown as mean ± SD. *, **p < 0.05, 0.01 vs. control.